CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-6512
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies ; volume:12 ; number:1 ; day:2 ; month:7 ; year:2021 ; pages:1-18 ; date:12.2021
Stem cell research & therapy ; 12, Heft 1 (2.7.2021), 1-18, 12.2021
- Creator
-
Marofi, Faroogh
Saleh, Marwan Mahmood
Rahman, Heshu Sulaiman
Wanich Suksatan
Al-Gazally, Moaed E.
Abdelbasset, Walid Kamal
Thangavelu, Lakshmi
Yumashev, Alexei Valerievich
Hassanzadeh, Ali
Yazdanifar, Mahboubeh
Motavalli, Roza
Pathak, Yashwant
Naimi, Adel
Baradaran, Behzad
Nikoo, Marzieh
Khiavi, Farhad Motavalli
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-021-02462-y
- URN
-
urn:nbn:de:101:1-2021101319170440879956
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Marofi, Faroogh
- Saleh, Marwan Mahmood
- Rahman, Heshu Sulaiman
- Wanich Suksatan
- Al-Gazally, Moaed E.
- Abdelbasset, Walid Kamal
- Thangavelu, Lakshmi
- Yumashev, Alexei Valerievich
- Hassanzadeh, Ali
- Yazdanifar, Mahboubeh
- Motavalli, Roza
- Pathak, Yashwant
- Naimi, Adel
- Baradaran, Behzad
- Nikoo, Marzieh
- Khiavi, Farhad Motavalli
- SpringerLink (Online service)
Other Objects (12)
CAR-NK cell therapy for hematological malignancies: recent updates from ASH 2022
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Combination of BCL-2 inhibitors and immunotherapy: a promising therapeutic strategy for hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting splicing for hematological malignancies therapy
CAR-NK cell therapy for hematological malignancies: recent updates from ASH 2022
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Combination of BCL-2 inhibitors and immunotherapy: a promising therapeutic strategy for hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting splicing for hematological malignancies therapy
CAR-NK cell therapy for hematological malignancies: recent updates from ASH 2022
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Combination of BCL-2 inhibitors and immunotherapy: a promising therapeutic strategy for hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
Role of CD47 in Hematological Malignancies